One Wealth Capital Management LLC Makes New Investment in Synopsys, Inc. $SNPS

One Wealth Capital Management LLC acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,206 shares of the semiconductor company’s stock, valued at approximately $595,000.

Other hedge funds also recently modified their holdings of the company. Stanley Laman Group Ltd. grew its position in Synopsys by 542.9% during the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock worth $6,353,000 after buying an additional 10,874 shares in the last quarter. Symphony Financial Ltd. Co. raised its holdings in Synopsys by 4,780.9% in the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after acquiring an additional 39,395 shares in the last quarter. Empirical Asset Management LLC bought a new stake in shares of Synopsys during the 3rd quarter valued at $773,000. Waverton Investment Management Ltd grew its holdings in shares of Synopsys by 15.0% during the 2nd quarter. Waverton Investment Management Ltd now owns 578,299 shares of the semiconductor company’s stock worth $296,630,000 after purchasing an additional 75,374 shares in the last quarter. Finally, Strategic Advisors LLC grew its holdings in shares of Synopsys by 76.3% during the 3rd quarter. Strategic Advisors LLC now owns 7,578 shares of the semiconductor company’s stock worth $3,739,000 after purchasing an additional 3,279 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Price Performance

SNPS stock opened at $442.30 on Friday. The company has a 50 day simple moving average of $467.50 and a 200 day simple moving average of $472.00. The stock has a market cap of $84.73 billion, a price-to-earnings ratio of 68.68, a P/E/G ratio of 3.51 and a beta of 1.15. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, beating analysts’ consensus estimates of $3.56 by $0.21. The firm had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The company’s quarterly revenue was up 65.6% on a year-over-year basis. During the same quarter last year, the business posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insiders Place Their Bets

In other Synopsys news, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 4,157 shares of company stock worth $1,945,036 in the last 90 days. 0.56% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Citigroup started coverage on shares of Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 price objective for the company. KeyCorp boosted their target price on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Morgan Stanley reaffirmed an “equal weight” rating and set a $480.00 price target (down from $550.00) on shares of Synopsys in a report on Wednesday, February 25th. The Goldman Sachs Group set a $600.00 price objective on shares of Synopsys and gave the company a “buy” rating in a research note on Wednesday, February 25th. Finally, Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and lowered their price objective for the company from $525.00 to $500.00 in a research report on Monday, December 8th. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Synopsys presently has a consensus rating of “Hold” and an average price target of $531.00.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.